Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Colorectal Cancer

Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma
Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma
Status: Enrolling
Updated:  4/23/2013
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma
Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma
Status: Enrolling
Updated: 4/23/2013
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
New York, NY
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated:  4/24/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
A Phase 1, Open-Label, Multiple-Escalating-Dose Study of DS-7423, an Orally Administered Dual PI3K/mTOR Inhibitor, in Subjects With Advanced Solid Tumors
Status: Enrolling
Updated: 4/24/2013
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Achieve Clinical Research
mi
from
Birmingham, AL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Clinical Research Associates
mi
from
Huntsville, AL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Clinical Research Associates
mi
from
Huntsville, AL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Atlanta Gastroenterology
mi
from
Atlanta, GA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Atlanta Gastroenterology
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Stroger Cook County
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Stroger Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Rush University Gastroenterologists
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Rush University Gastroenterologists
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Jesse Brown VA
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Jesse Brown VA
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Rockford Gastroenterology Associates, Ltd.
mi
from
Rockford, IL
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Gastroenterology Associates
mi
from
Baton Rouge, LA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Gastroenterology Associates
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Chevy Chase Clinical Research
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Commonwealth Clinical Studies
mi
from
Brockton, MA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Commonwealth Clinical Studies
mi
from
Brockton, MA
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Long Island Gastrointestinal Group
mi
from
Great Neck, NY
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Long Island Gastrointestinal Group
mi
from
Great Neck, NY
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Asheville Gastroenterology
mi
from
Asheville, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Southern Gastroenterology Associates
mi
from
New Bern, NC
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Northwest Gastroenterology Clinic, LLC
mi
from
Portland, OR
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Gastro One
mi
from
Germantown, TN
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Gastro One
mi
from
Germantown, TN
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive Health Specialists
mi
from
Tyler, TX
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated:  5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies
Status: Enrolling
Updated: 5/22/2013
Digestive and Liver Disease Specialists
mi
from
Norfolk, VA
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
Florida Hospital, Center for Colon & Rectal Surgery
mi
from
Atlamonte Springs, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
18308 Murdock Circle, Suite 108
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated:  6/16/2013
CoxHealth Hospital, Colorectal Department
mi
from
Springfield, MO
A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417
Status: Enrolling
Updated: 6/16/2013
CoxHealth Hospital, Colorectal Department
mi
from
Springfield, MO
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Alhambra, CA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Alhambra, CA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
San Francisco, CA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Spring Valley, CA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Coral Gables, FL
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Miami, FL
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
South Miami, FL
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Orlando, FL
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Chicago, IL
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Marrero, LA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Marrero, LA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Elkridge, MD
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Elkridge, MD
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Kansas City, MO
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
New York, NY
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Rochester, NY
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Levittown, PA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Levittown, PA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Providence, RI
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Nashville, TN
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Houston, TX
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated:  6/26/2013
Clinical Research Facility
mi
from
Richmond, VA
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003 AM5)
A Phase III Clinical Trial to Study the Tolerability and Immunogenicity of V503, a Multivalent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine, in 16- to 26-Year-Old Men and 16- to 26-Year-Old Women
Status: Enrolling
Updated: 6/26/2013
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection, in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Status: Enrolling
Updated:  7/1/2013
NEA Baptist Clinic
mi
from
Jonesboro, AR
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection, in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
Status: Enrolling
Updated: 7/1/2013
NEA Baptist Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials